Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer

Nat Commun. 2020 Apr 30;11(1):2218. doi: 10.1038/s41467-020-15721-y.

D M Janzen¹, E Tiourin¹, J A Salehi¹, D Y Paik¹, J Lu², M Pellegrini^{2

3}, S Memarzadeh^{4

5

6}

¹ Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
² Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
³ Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
⁴ Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA. smemarzadeh@mednet.ucla.edu.
⁵ Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA, 90095, USA. smemarzadeh@mednet.ucla.edu.
⁶ The VA Greater Los Angeles Health Care System, Los Angeles, CA, 90073, USA. smemarzadeh@mednet.ucla.edu.

Abstract

This Article has been retracted; see accompanying Retraction Note.